scPharmaceuticals Inc. (SCPH)
3.20
-0.08 (-2.44%)
At close: Mar 03, 2025, 3:59 PM
3.24
1.25%
After-hours: Mar 03, 2025, 06:20 PM EST
scPharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 46.81M | 71.06M | 74.27M | 105.28M | 72.81M | 89.66M | 118.3M | 39.28M | 1.57M |
| Short-Term Investments | 29.2M | 47.13M | 1.01M | 33.28M | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | 182K | 182K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 82K | 267K | 283K | 132K | 148K | 192K | 189K | 6K | 5K |
| Receivables | 4.49M | n/a | n/a | n/a | 310K | 479K | 655K | 349K | 104K |
| Inventory | 8.84M | 1.23M | n/a | n/a | 2.44M | 1.57M | 823K | 101K | 126K |
| Other Current Assets | 3.6M | 2.46M | 2.97M | 2.73M | 2.71M | 1.94M | 930K | 109K | 141K |
| Total Current Assets | 92.94M | 123.31M | 78.28M | 107.83M | 75.65M | 91.89M | 119.88M | 39.74M | 1.82M |
| Property-Plant & Equipment | 1.46M | 620K | 479K | 908K | 1.31M | 1.67M | 1.98M | 26K | 23K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.54M | 887K | 762K | 1.22M | 1.64M | 1.86M | 2.17M | 32K | 28K |
| Total Assets | 94.48M | 124.19M | 79.04M | 109.05M | 77.28M | 93.75M | 122.05M | 39.77M | 1.85M |
| Account Payables | 4M | 1.52M | 544K | 1.67M | 1.14M | 587K | 1.59M | 1.55M | 684K |
| Deferred Revenue | 73K | n/a | 4M | n/a | n/a | 2.57M | 3.06M | n/a | n/a |
| Short-Term Debt | 352K | 1.13M | 10.76M | 3.33M | 814K | 3.16M | 556K | n/a | n/a |
| Other Current Liabilities | 8.71M | 4.71M | 3.54M | 4.29M | 3.23M | 2.76M | 2.87M | 2.19M | 1.32M |
| Total Current Liabilities | 13.13M | 7.42M | 14.85M | 9.32M | 5.24M | 6.67M | 5.21M | 3.74M | 2M |
| Long-Term Debt | 40.09M | 36.8M | 7.35M | 17.34M | 19.86M | 8.18M | 10.79M | n/a | n/a |
| Other Long-Term Liabilities | 4.03M | 7.54M | 367K | 219K | 823K | 159K | 52K | 73.11M | 18.08M |
| Total Long-Term Liabilities | 44.13M | 44.35M | 7.72M | 17.56M | 20.68M | 8.34M | 10.84M | 73.11M | 18.08M |
| Total Liabilities | 57.26M | 51.76M | 22.57M | 26.88M | 25.92M | 15.01M | 16.05M | 76.85M | 20.09M |
| Total Debt | 40.27M | 37.37M | 17.64M | 20.21M | 20.27M | 11.34M | 11.34M | n/a | n/a |
| Common Stock | 4K | 3K | 3K | 3K | 2K | 2K | 2K | 1K | 1K |
| Retained Earnings | -281.35M | -226.54M | -189.7M | -161.66M | -129.46M | -96.46M | -67.02M | -43.2M | -18.82M |
| Comprehensive Income | -1K | 32K | -1K | 1K | n/a | -600K | -26K | -9K | -4K |
| Shareholders Equity | 37.22M | -226.54M | -189.7M | -161.66M | -129.46M | -96.46M | 106M | -37.07M | -18.24M |
| Total Investments | 29.2M | 47.13M | 1.01M | 33.28M | 182K | n/a | n/a | n/a | n/a |